-
Diagnostics World News Brief | Renalytix AI announced today that it has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA), for its lead diagnostic, KidneyIntelX. This is the first such designation for an AI-enabled diagnostic for kidney disease publicly announced by any company.
May 2, 2019
-
Diagnostics World News | April featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including QIAGEN, Charles River, AiLife Diagnostics, and more.
May 1, 2019
-
Diagnostics World News | With current technologies in molecular diagnostics being too expensive, time-consuming, and lacking the ability to conduct multiple tests with a single sample, QuantuMDx is pushing its portable molecular diagnostic kit, called Q-POC, that analyzes samples at the point-of-care and provides results within 30 minutes.
Apr 25, 2019
-
Diagnostics World News | Liquid biopsies are emerging as rapid and cost-effective tools for the management of cancer patients, making it difficult to sniff out hope from hype.
Apr 24, 2019
-
Diagnostics World News | There is an urgent need to identify biomarkers that accurately predict for treatment response and guide the selection of novel combination therapies for patients who acquire resistance.
Apr 23, 2019
-
Diagnostics World News | Pathologists around the world over—65,000 of them in 163 countries at last count—appear enamored of a free and easy-to-use digital pathology platform that allows slides to be aggregated irrespective of the scanner that created them.
Apr 18, 2019
-
Diagnostics World News | During the Molecular Medicine Tri-Conference, dozens of early-career scientists presented their solutions to real-world clinical, scientific, and organizational problems at the event's poster viewing sessions.
Apr 10, 2019
-
Diagnostics World News | At the Molecular Medicine Tri-Conference in San Francisco, Gerald Kost gave insight into point-of-care testing's impact in Central Vietnam.
Apr 9, 2019
-
Diagnostics World Contributed Commentary | Variant interpretation has come a long way since the days when single-gene or even single-variant tests represented the cutting edge in clinical labs. With the explosion of next-generation sequencing (NGS) and other multiplex-friendly technologies, variant analysts who could once easily perform manual review of every mutation, now face an onslaught of data.
Apr 5, 2019
-
Diagnostics World News Brief | The American Society of Human Genetics, along with several co-signing organizations, issued a position statement today outlining whether, and to what extent, there is a responsibility to recontact genetic and genomic research participants.
Apr 4, 2019
-
Diagnostics World News Brief | The Bill and Melinda Gates Foundation and the Day One Fund, launched by Amazon CEO Jeff Bezos, have teamed up to donate $15 million to the Alzheimer's Drug Discovery Foundation (ADDF) in support of its Diagnostics Accelerator research program. This latest donation brings the total program funding to $50 million since its launch in July 2018.
Apr 3, 2019